X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

NEUROPHARMACOLOGY

期刊標題檢索 NEUROPHARMACOLO 最新評論: Is there a specific journal template for the manuscript, or should I w... (2023-05-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[NEUROPHARMACOLOGY]您好,您是該頁面的第 94353 位訪客。

期刊簡介
期刊名稱NEUROPHARMACOLOGY NEUROPHARMACOLOGY
LetPub Score
8.0
51 ratings
Rate

Reputation
8.8

Influence
6.9

Speed
9.4

期刊簡稱NEUROPHARMACOLOGY
ISSN0028-3908
E-ISSN1873-7064
h-index150
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.001.4891.105
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q136 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Cellular and Molecular Neuroscience
Q116 / 97

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).
官方網站http://www.journals.elsevier.com/neuropharmacology/
在線稿件提交https://www.editorialmanager.com/NEUROPHARM
開放訪問No
出版商Elsevier Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率月2回刊行
創刊年1970
每年文章數230每年文章數趨勢
黃金OA百分比35.31%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ166/310
PHARMACOLOGY & PHARMACYSCIEQ157/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0028-3908%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【NEUROPHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS NEUROSCIENCEH-index: 357

    CiteScore: 35.00
    NATURE NEUROSCIENCEH-index: 375

    CiteScore: 38.60
    Molecular NeurodegenerationH-index: 66

    CiteScore: 23.00
    NeuronH-index: 430

    CiteScore: 24.50
    TRENDS IN NEUROSCIENCESH-index: 269

    CiteScore: 26.50
    Annual Review of NeuroscienceH-index: 224

    CiteScore: 25.30
    Journal of NeuroinflammationH-index: 92

    CiteScore: 15.90
    PROGRESS IN NEUROBIOLOGYH-index: 212

    CiteScore: 12.80
    NeurotherapeuticsH-index: 100

    CiteScore: 11.00
    GLIAH-index: 148

    CiteScore: 13.10
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF NEUROSCIENCE185707
    NEUROSCIENCE168127
    BRAIN RESEARCH139945
    Journal of Neuroinflammation131833
    MOLECULAR NEUROBIOLOGY128498
    Neuron121472
    NEUROSCIENCE LETTERS114987
    CNS Neuroscience & Therapeutics109921
    NATURE NEUROSCIENCE98227
    CEREBRAL CORTEX97890
  •  

    NEUROPHARMACOLOGY NEUROPHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [NEUROPHARMACOLOGY] 的評論撰寫評論
作者: Ruby Saul


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-31 18:05:57 評論於
Is there a specific journal template for the manuscript, or should I write it myself according to the requirements?
(0) 讚! | Ruby Saul

作者: Ruby Saul


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-31 08:33:56 評論於
Do you have a specialized neuropharmacology journal template, or are you writing according to requirements yourself?
(0) 讚! | Ruby Saul

作者: zqyzqy111


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-03 11:40:25 評論於
Excuse me, how are you all doing now?
(0) 讚! | zqyzqy111

作者: xwh123


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2023-02-24 14:42:15 評論於
It's really too slow. It has been a month already, still with the editor...
(0) 讚! | xwh123

作者: 虚徒山蝶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-23 20:04:37 評論於
What is the format of the raw data, can the cut wb be used?
(0) 讚! | 虚徒山蝶

作者: 四风平晓


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-25 19:42:11 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Research focus: electrophysiology 
Experience sharing: First review took two months, with one major revision and one minor revision. The editor asked for a major revision, and it took a month to collect additional data. After submission, it took another month to receive the final decision. The reviewers asked very detailed questions which felt quite challenging
(0) 讚! | 四风平晓

作者: 阳飇小仙女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-23 16:27:55 評論於
Hello, may I ask if the WB raw data you provided is a picture of the whole board glue? I submitted mine on March 16th and it is still in the editing hands
(0) 讚! | 阳飇小仙女

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-10 19:12:21 評論於
Journal
(0) 讚! | 破戒阳平

作者: 淑亮酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-08 13:13:09 評論於
Submission acceptance rate: 50.0
Main research direction: Neurodegenerative diseases
Experience sharing: The first submission was rejected the next day because the image format did not meet the requirements. The second submission was made on 2.24 and showed "under review" on 3.7. The corresponding author submitted the document after the second submission, only the corresponding author could see the status of the second submission, and the first author could not see the submission record of the second time
(0) 讚! | 淑亮酱大魔王

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:43:44 評論於
Model diagram is to illustrate your theoretical model. This diagram is optional for submission
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:00:49 評論於
The model diagram can vividly and directly display the overall idea of the article
(0) 讚! | 维尔娜菲茨杰拉德

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:19:07 評論於
Is a model diagram necessary?
(0) 讚! | 北国博达

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:02:49 評論於
Is the model diagram helpful or harmful to reviewers' attitudes towards manuscripts?
(0) 讚! | 陶宜三岁啦

作者: 削月利伟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-03 10:42:18 評論於
Not happy now
(0) 讚! | 削月利伟

作者: 九阳阳冰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-11 22:14:07 評論於
How long after did you review it?
(0) 讚! | 九阳阳冰

作者: 东风太枝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-01 16:58:05 評論於
How long did you spend on the first review?
(0) 讚! | 东风太枝

作者: 东风太枝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-30 14:45:49 評論於
How long did you spend on the first review?
(0) 讚! | 东风太枝

作者: 削月昕妤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-03-09 12:20:04 評論於
Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: Accepted after major revisions, lasted for 4 months, and graduated safely
(0) 讚! | 削月昕妤

作者: 削月昕妤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-25 21:44:06 評論於
Review speed: 2.0 | Submission hit rate: 95.0 Experience sharing: It's been nearly three weeks since the major revision was submitted, but there has been no response at all
(0) 讚! | 削月昕妤

作者: 朝曦mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-23 22:33:51 評論於
Focused Research Area: Neuropharmacology
Experience Sharing: Submitted on 20.12.07, status on 21.01.24 is With Editor. Has anyone encountered this situation before? Should I follow up with the editor? Urgently waiting for graduation
(0) 讚! | 朝曦mio

作者: 削月昕妤


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-14 14:24:57 評論於
Will you accept directly after the major repair?
(0) 讚! | 削月昕妤

作者: Lydia Raphael


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-23 10:36:52 評論於
Do you have the complete original WB image? Do you need the whole piece of gel?
(0) 讚! | Lydia Raphael

作者: Elvira Nichols


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-07-11 23:29:34 評論於
Review speed: 2.0 | Submission success rate: 50.0 
Experience sharing: Submitted in May 2019, revised in June, received revisions in July within a week. Personally, I feel the speed is very fast
(0) 讚! | Elvira Nichols

作者: 惠泽小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-19 23:28:29 評論於
My research focus is on neuropharmacology. It took two months for the first review, then a major revision, followed by a one-month second review before acceptance
(0) 讚! | 惠泽小可爱

作者: 贾小盼


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2019-06-19 09:19:47 評論於
My research direction is neuropsychopharmacology. It took two months for the first round of peer review and major revisions, and then another month for the second round before it was accepted by the journal.

(7) 讚! | 贾小盼

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [NEUROPHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*